Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia
Clinical trial NCT01088984 · COMPLETED
Trial details
- NCT number
- NCT01088984
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-08-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.